Weight loss drugs are getting more popular, even for teenagers and pre-teens -- but while many doctors have reported ...

WeightWatchers, the legacy company that has helped people lose weight for more than 62 years, filed for bankruptcy on Tuesday ...

Investors are worried Novo Nordisk's competition with Eli Lilly is heating up and that the first-to-market GLP-1 leader is ...

Shares of WW International Inc. plunged Wednesday after the health and wellness company known as WeightWatchers filed for bankruptcy, facing a mounting debt burden that offering weight-loss drugs ...

WeightWatchers filed for Chapter 11 bankruptcy in an effort to reduce its debt by more than $1 billion. However, CEO Tara ...

As we learn more about GLP-1 drugs like Wegovy and Zepbound, early research suggests that they may be able to improve COPD ...

Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies. Compare side effects here.

Global wellness giant Weight Watchers has filed for bankruptcy, while weight-loss drug maker Novo Nordisk cut its full-year forecasts. Read more.

GLP-1 receptor agonists remain blockbuster drugs for weight management for people with overweight or obesity. Increasingly, ...

Shares have slumped 60% since the Wall Street Journal reported in April that the company was preparing to file for bankruptcy ...

WeightWatchers, the 62-year-old program that revolutionized dieting for millions of people around the world, has filed for ...

Novo Nordisk Q1 sales missed estimates despite strong growth in Wegovy and Ozempic, prompting a cut to its 2025 guidance amid ...